DADC
NERV icon

D.A. Davidson & Co’s Minerva Neurosciences NERV Stock Holding History

D.A. Davidson & Co’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,683
Closed -$819K – 2365
2016
Q1 		$819K Buy
16,683
+6,725
+68% +$287K 0.03% 425
2015
Q4 		$483K Buy
9,958
+428
+4% +$17.9K 0.02% 550
2015
Q3 		$400K Buy
9,530
+1
+0% +$46 0.01% 604
2015
Q2 		$442K Buy
+9,529
New +$407K 0.01% 612

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

D.A. Davidson & Co's NERV Position: Q2 2016 in Review

D.A. Davidson & Co sold out of Minerva Neurosciences (NERV) in Q2 2016, closing a stake of 16,683 shares — an estimated $819K sold.

D.A. Davidson & Co first reported a position in NERV in Q2 2015 and held it in 4 quarters. The position peaked at $819K in Q1 2016. 63 funds tracked by Wall St. Rank hold NERV as of Q2 2016.

  • D.A. Davidson & Co reported no remaining Minerva Neurosciences position as of Q2 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 16,683 Minerva Neurosciences shares in Q2 2016, an estimated $819K.
  • D.A. Davidson & Co first reported a position in Minerva Neurosciences in Q2 2015 and held it in 4 quarters.
  • D.A. Davidson & Co's Minerva Neurosciences position peaked at $819K in Q1 2016.
  • 63 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2016.

Based on D.A. Davidson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.